Nifedipine ER Clinical Trials

• Two Dose Regimens of Nifedipine for the Management of Preterm Labor
  ClinicalTrials.gov Identifier: NCT00137501 - Recruiting
  Labor, Premature
  
• Multiphase Efficacy Study of venlafaxine ER to Treat Recurrent Depression
  ClinicalTrials.gov Identifier: NCT00046020 - Active, not recruiting
  Depression
  
• Bryophyllum vs. Nifedipine
  ClinicalTrials.gov Identifier: NCT00391339 - Not yet recruiting
  Tocolysis
  
• Indomethacin Versus Nifedipine for Preterm Labor Tocolysis
  ClinicalTrials.gov Identifier: NCT00486824 - Recruiting
  Obstetric Labor, Premature
  
• Study of DVS-233 SR and Venlafaxine ER in Adult Outpatients With Major Depressive Disorder
  ClinicalTrials.gov Identifier: NCT00087737 - Active, not recruiting
  Major Depressive Disorder
  
• Study Of DVS-233 SR And Venlafaxine ER In Adult Outpatients With Major Depressive Disorder
  ClinicalTrials.gov Identifier: NCT00090649 - Active, not recruiting
  Major Depressive Disorder
  
• Cetuximab and Carbo for ER/PR/HER2 Negative BC
  ClinicalTrials.gov Identifier: NCT00420329 - Active, not recruiting
  Breast Cancer
  
• Efficacy Study of Topical Application of Nifedipine Cream to Treat Vulvar Vestibulitis
  ClinicalTrials.gov Identifier: NCT00496184 - Recruiting
  Vulvar Diseases; Vulvar Pain; Vestibulitis; Vestibulodynia; Vulvodynia
  
• Study Evaluating the Pharmacokinetics of Venlafaxine ER and Desvenlafaxine SR in Healthy Subjects
  ClinicalTrials.gov Identifier: NCT00329186 - Active, not recruiting
  Depressive Disorder, Major
  
• Trial of Magnesium Sulfate Tocolysis Versus Nifedipine Tocolysis in Women With Preterm Labor
  ClinicalTrials.gov Identifier: NCT00306462 - Recruiting
  Premature Birth; Premature Labor
  
• Preoperative Cisplatin in Early Stage Breast Cancer
  ClinicalTrials.gov Identifier: NCT00148694 - Active, not recruiting
  Breast Cancer; ER Negative Breast Cancer; PR Negative Breast Cancer; HER-2 Negative Breast Cancer
  
• Extended Release Nifedipine Treatment as Maintenance Tocolysis to Prevent Preterm Delivery
  ClinicalTrials.gov Identifier: NCT00525486 - Not yet recruiting
  Preterm Labor
  
• Risperidone Vs. Bupropion ER Augmentation of SSRIs in Treatment-Resistant Depression
  ClinicalTrials.gov Identifier: NCT00179244 - Active, not recruiting
  Unipolar Depression
  
• A Case Management Intervention to Prevent ER Visits in HIV-Infected Persons
  ClinicalTrials.gov Identifier: NCT00187590 - Active, not recruiting
  HIV
  
• A Study to Evaluate Effectiveness and Safety of ER OROS Paliperidone in Patients With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00396565 - Active, not recruiting
  Schizophrenia
  
• Depakote-ER for Depressive and Bipolar Depression
  ClinicalTrials.gov Identifier: NCT00226343 - Active, not recruiting
  Bipolar Disorder
  
• Double-Blind, Placebo-Controlled Divalproex Sodium ER in Bipolar I or Bipolar II Depression
  ClinicalTrials.gov Identifier: NCT00194116 - Active, not recruiting
  Bipolar Disorder
  
• Comparative Study of Oestradiol Suppression: Zoladex 10.8mg/3 Month vs. 3.6mg/Month in ER +ve EBC Pre-Menopausal Patients
  ClinicalTrials.gov Identifier: NCT00303524 - Active, not recruiting
  Breast Cancer
  
• A Study of Nifecardia SRFC and Adalat OROS in the Treatment of Patients with Essential Hypertension
  ClinicalTrials.gov Identifier: NCT00173667 - Not yet recruiting
  Hypertension
  
• Safety And Efficacy Study Of Depakote ER To Treat Pediatric Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00199966 - Active, not recruiting
  Bipolar Disorder
  
• Paliperidone ER Study of Economic, Functional, and Clinical Outcomes.
  ClinicalTrials.gov Identifier: NCT00488891 - Recruiting
  Schizophrenia
  
• Study of Gabapentin Extended Release (G-ER) in the Treatment of Vasomotor (Hot Flashes/Hot Flushes) Symptoms in Postmenopausal Women
  ClinicalTrials.gov Identifier: NCT00511953 - Active, not recruiting
  Hot Flashes
  
• Placebo Controlled Trial of Depakote ER in Alcohol Dependent Patients With Mood and/or Anxiety Symptoms
  ClinicalTrials.gov Identifier: NCT00202514 - Active, not recruiting
  Alcoholism; Alcohol Related Disorders; Mood Disorders
  
• Study of Depakote ER for the Treatment of Mania in Children Ages 6-12 With Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00181727 - Active, not recruiting
  Bipolar Disorder; Mania
  
• Brief Intervention to Reduce STDs in ER Drug Users - 1
  ClinicalTrials.gov Identifier: NCT00218400 - Recruiting
  Substance-Related Disorders; Sexual Risk Behaviors
  
• A Study to Evaluate the Efficacy and Safety of Adjustable Doses of Extended-Release (ER) Paliperidone Compared With Placebo, in Combination With Lithium or Valproate, to Treat Manic and Mixed Episodes in Patients With Bipolar I Disorder
  ClinicalTrials.gov Identifier: NCT00309686 - Active, not recruiting
  Affective Psychosis, Bipolar; Bipolar Disorder; Mania
  
• Naturalistic Study, Comparison of Divalproex ER and Quetiapine for Adults With Acute Mania or Mixed Episodes
  ClinicalTrials.gov Identifier: NCT00397020 - Recruiting
  Bipolar Disorder
  
• A Study to Evaluate the Efficacy and Safety of Flexible Doses of Extended-Release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo in Patients With Bipolar I Disorder
  ClinicalTrials.gov Identifier: NCT00309699 - Active, not recruiting
  Bipolar Disorder; Mood Disorders
  
• Comparing Compliance, Tolerability, Efficacy and Adverse Events in Bipolar Tients From Valproic Acid to Depakote ER.
  ClinicalTrials.gov Identifier: NCT00211250 - Recruiting
  Mood Disorder
  
• Depakote ER in Bipolar Depression
  ClinicalTrials.gov Identifier: NCT00186186 - Active, not recruiting
  Depression, Bipolar
  
• Study to Measure the Safety of Paliperidone ER (Extended-Release) in Patients With Liver Disease
  ClinicalTrials.gov Identifier: NCT00535145 - Recruiting
  Schizophrenia; Psychotic Disorders; Schizoaffective Disorder
  
• Panic Disorder Study
  ClinicalTrials.gov Identifier: NCT00038896 - Active, not recruiting
  Panic Disorder
  
• Panic Disorder Study
  ClinicalTrials.gov Identifier: NCT00044772 - Active, not recruiting
  Panic Disorder
  
• Evaluate the Effect of Nebulized Budesonide and Oral Corticosteroids on Wheezing Episode Relapse in Children Following Discharge From the ER/Outpatient Care Facility
  ClinicalTrials.gov Identifier: NCT00189436 - Recruiting
  Asthma
  
• Tolerability and Efficacy of Depakote-ER in the Elderly
  ClinicalTrials.gov Identifier: NCT00318929 - Recruiting
  Elderly; Epilepsy; Seizures
  
• Study of Paliperidone ER in Adolescents and Young Adults With Autism
  ClinicalTrials.gov Identifier: NCT00549562 - Recruiting
  Autism
  
• Valproic Acid (Depakote ER) in Patients With Advanced Thyroid Cancer
  ClinicalTrials.gov Identifier: NCT00525135 - Recruiting
  Head and Neck Cancer
  
• An Open Label Multicentre Study to Determine the Dose Distribution of Paliperidone ER in Patients With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00473434 - Recruiting
  Schizophrenia
  
• A Study of the Efficacy and Safety of One Dosage of Paliperidone Extended Release (ER) in Treating Patients With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00524043 - Recruiting
  Schizophrenia
  
• Study to Evaluate Symptoms in Patients Treated With Nebivolol or Metoprolol Extended-Release (ER) for Hypertension
  ClinicalTrials.gov Identifier: NCT00547300 - Recruiting
  Hypertension
  
• Divalproex Sodium ER in Adult Autism
  ClinicalTrials.gov Identifier: NCT00211796 - Recruiting
  Autism
  
• A Trial to Explore the Tolerability, Safety and Effectiveness of Paliperidone ER (Extended Release) Flexible Dosing in Patients With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00460512 - Recruiting
  Schizophrenia
  
• Depakote Extended Release (ER) Versus Seroquel for Agitated Behaviors in Nursing Home Care Unit Patients With Dementia
  ClinicalTrials.gov Identifier: NCT00315900 - Recruiting
  Agitation; Dementia
  
• A Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Paliperidone Extended Release (ER) in the Treatment of Schizophrenia in Adolescent Patients.
  ClinicalTrials.gov Identifier: NCT00518323 - Recruiting
  Schizophrenia
  
• A Trial to Explore the Tolerability, Safety and Treatment Response of the Antipsychotic Paliperidone ER (Extended Release) Using Flexible Dosing in Patients With Acute Schizophrenia
  ClinicalTrials.gov Identifier: NCT00566631 - Recruiting
  Schizophrenia
  
• Pain Study to See if Ultram ER Will Provide Relief to Subjects Whose Pain is Not Well Controlled by Narcotics
  ClinicalTrials.gov Identifier: NCT00505531 - Recruiting
  Chronic Pain
  
• Open-Label Depakote ER in Patients With Bipolar I or II Depression and Alcohol Abuse or Dependence
  ClinicalTrials.gov Identifier: NCT00204503 - Active, not recruiting
  Bipolar I or II Depression and Alcohol Abuse or Dependence
  
• Efficacy, Safety, Tolerability of Pramipexol ER Versus Pramipexol IR Versus Placebo in Early PD Patients
  ClinicalTrials.gov Identifier: NCT00479401 - Recruiting
  Parkinson Disease
  
• Preoperative Cisplatin and Bevacizumab in ER-, PR-, Her-2 Negative Breast Cancer
  ClinicalTrials.gov Identifier: NCT00580333 - Recruiting
  Breast Cancer
  
• Trial Evaluating the Safety and Efficacy of 2 Doses of ER OROS Paliperidone in Acute Adult Schizophrenics
  ClinicalTrials.gov Identifier: NCT00077714 - Completed
  Schizophrenia
  
• Open-Label Study of Flexible-Dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia.
  ClinicalTrials.gov Identifier: NCT00488319 - Recruiting
  Dementia Praecox.; Schizophrenia; Psychotic Disorders; Schizophrenic Disorders
  
• An Open-Label Extension Study With Flexible Dosing of Extended-Release (ER) Tapentadol (CG5503) to Treat Patients With Moderate to Severe Chronic Pain
  ClinicalTrials.gov Identifier: NCT00487435 - Recruiting
  Low Back Pain; Pain; Osteoarthritis
  
• Phase II Letrozole + Herceptin in Her2neu Positive, ER and/or PR Receptor (+),Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00134680 - Active, not recruiting
  Metastatic breast cancer
  
• A 12-Week Study of Pramipexole ER in Patients With Parkinson?s Disease, Followed by a 52-Week Long-Term Treatment Period
  ClinicalTrials.gov Identifier: NCT00560508 - Recruiting
  Parkinson Disease
  
• Androgen Therapy for Management of Estrogen/Progesterone Receptor Negative ER(-)PR(-) Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00303615 - Recruiting
  Metastatic Breast Cancer
  
• A Study to Evaluate the Effectiveness and Safety of Tapentadol(CG5503) Extended Release (ER) in Patients With Moderate to Severe Chronic Low Back Pain
  ClinicalTrials.gov Identifier: NCT00449176 - Recruiting
  Low Back Pain
  
• An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects With Hyperlipidemia or Mixed Dyslipidemia (SUPREME)
  ClinicalTrials.gov Identifier: NCT00465088 - Recruiting
  Hyperlipidemia; Mixed Dyslipidemia
  
• Phase II Trial of Cetuximab Alone and in Combination With Carboplatin in ER-Negative, PR-Negative, HER-2 Nonoverexpressing Metastatic Breast Cancers (LCCC 0403)
  ClinicalTrials.gov Identifier: NCT00492375 - Recruiting
  Metastatic Breast Cancer
  
• Does The Addition Of Divalproex Sodium ER To An Atypical Antipsychotic Drug (APD) Improve Cognition And Psychopathology In Outpatients With Schizophrenia (SCH) Or Schizoaffective Disorder (SAD)?
  ClinicalTrials.gov Identifier: NCT00306475 - Recruiting
  Schizophrenia; Schizoaffective Disorder
  
• Overnight Switch Trial From Pramipexole IR to Pramipexole ER in Patients With Early Parkinson Disease
  ClinicalTrials.gov Identifier: NCT00558025 - Recruiting
  Parkinson Disease
  
• Trial of Letrozole Plus OSI-774 (Tarceva) in Post-Menopausal Women With Estrogen Receptor (ER) and/or Progesterone Receptor (PR)-Positive Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00179296 - Recruiting
  Breast Cancer; Neoplasm Metastasis
  
• A Phase III Trial to Evaluate the Effectiveness and Safety of Tapentadol(CG5503) Extended Release (ER) in Patients With Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee
  ClinicalTrials.gov Identifier: NCT00421928 - Recruiting
  Pain; Osteoarthritis, Knee
  
• A Study to Measure the Effect of Tolterodine ER on the Thickness of the Bladder Wall in Patients with Overactive Bladder
  ClinicalTrials.gov Identifier: NCT00137397 - Completed
  Urinary Incontinence
  
• Phase I-II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 in Advanced Solid Malignancies, and Efficacy in HER2+ or ER+ Locally Advanced or Metastatic Breast Cancer Patients.
  ClinicalTrials.gov Identifier: NCT00526045 - Recruiting
  Breast Cancer; Hematologic Neoplasms
  
• Long-Term Safety Study of Open-Label Pramipexole ER in Patients With Advanced PD
  ClinicalTrials.gov Identifier: NCT00577460 - Not yet recruiting
  Parkinson Disease
  
• PREDICT TRIAL- Neoadjuvant Treatment of Locally Advanced Breast Cancer With Letrozole in Postmenopausal Women Expressing Hormonal Receptors ( ER and PR)
  ClinicalTrials.gov Identifier: NCT00237133 - Recruiting
  Locally Advanced Breast Cancer
  
• Use of Sustained Release Antiepileptic Medication (Depakote® ER) for Pediatric Epilepsy in a Mental Retardation/Developmental Disorder Population
  ClinicalTrials.gov Identifier: NCT00207935 - Recruiting
  Epilepsy; Mental Retardation; Developmental Disabilities
  
• Tailored Teen Alcohol and Violence Prevention in the ER
  ClinicalTrials.gov Identifier: NCT00251212 - Recruiting
  Violence; Alcohol Abuse
  
• Maintenance Treatment with Capecitabine Vs. Observation in ER, PgR and HER2 Negative Breast Cancer Patients.
  ClinicalTrials.gov Identifier: NCT00130533 - Recruiting
  Breast cancer.
  
• Evaluating Extended-Release (ER) OROS Paliperidone Versus Placebo on Sleep in Schizophrenia Subjects
  ClinicalTrials.gov Identifier: NCT00105326 - Completed
  Schizophrenia; Insomnia
  
• Phase II Study of Carboplatin and Bevacizumab (Avastin) for ER Neg, PR Neg, and HER2/Neu Neg Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00517361 - Recruiting
  Metastatic Breast Cancer
  
• Prophylactic Effect of Nifedipine on Further Decline in Renal Function in Patients Undergoing Open-Heart Surgery
  ClinicalTrials.gov Identifier: NCT00244530 - Completed
  Kidney Failure, Chronic; Coronary Artery Disease
  
• Study of Dasatinib (BMS-354825) in Patients With Advanced Estrogen/Progesterone Receptor-Positive (ER+/PR+) or Her2/Neu-Positive (Her2/Neu+)Breast Cancer
  ClinicalTrials.gov Identifier: NCT00371345 - Recruiting
  Breast Cancer; Metastasis
  
• Safety and Tolerability Study of Extended Release (ER) Galantamine in Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00082602 - Completed
  Alzheimer's Disease
  
• A Study to Evaluate the Effectiveness and Safety of Extended-Release (ER) Paliperidone Compared With Placebo in Delaying the Recurrence of Symptoms in Bipolar I Disorder
  ClinicalTrials.gov Identifier: NCT00490971 - Recruiting
  Manic-Depressive Psychosis; Affective Disorder, Bipolar; Bipolar Disorder; Depression, Bipolar; Manic Disorder
  
• Magnesium Sulfate Versus Nifedipine for the Acute Tocolysis of Preterm Labor: A Prospective, Randomized Trial
  ClinicalTrials.gov Identifier: NCT00185900 - Completed
  Obstetric Labor, Premature
  
• Quetiapine SR and Divalproex Sodium ER in the Treatment of Anxiety in Bipolar Disorder With Panic Disorder and/or GAD
  ClinicalTrials.gov Identifier: NCT00579280 - Recruiting
  Bipolar Disorder; Panic Disorder; Generalized Anxiety Disorder
  
• Treatment of Acute Asthma in ER With Combination of Systemic Steroids and Inhaled Steroids
  ClinicalTrials.gov Identifier: NCT00397267 - Not yet recruiting
  Asthma Exacerbation
  
• Nifedipine for the Maintenance Tocolysis of Preterm Labor: Comparison to Placebo in a Prospective, Randomized, Double Blind Trial
  ClinicalTrials.gov Identifier: NCT00185952 - Completed
  Preterm Labor
  
• Compliance With Once-Daily Divalproex Extended-Release Tablets (Depakote-ER) Versus Multiple-Daily Dose Valproic Acid Capsules (Depakene) in Epilepsy:
  ClinicalTrials.gov Identifier: NCT00356018 - Not yet recruiting
  Epilepsy
  
• Study of Drugs for High Blood Pressure and High Cholesterol in American Indians with Type 2 Diabetes at High Risk of Kidney or Heart Disease
  ClinicalTrials.gov Identifier: NCT00004266 - Completed
  Diabetic Nephropathy
  
• Phase II Metastatic ER+/PgR+ Nolvadex +/- Iressa Study
  ClinicalTrials.gov Identifier: NCT00229697 - Completed
  Breast Neoplasms
  
• Phase II Neoadjuvant ER+/PgR + Arimidex +/- Iressa Study
  ClinicalTrials.gov Identifier: NCT00255463 - Completed
  Breast Cancer
  
• Congenital Adrenal Hyperplasia: Calcium Channels as Therapeutic Targets
  ClinicalTrials.gov Identifier: NCT00000102 - Completed
  Congenital Adrenal Hyperplasia
  
• Study on Pre-Menopausal Patients With Advanced ER and PR + BC Treated With Arimidex Plus Zoladex
  ClinicalTrials.gov Identifier: NCT00235937 - Completed
  Breast Cancer
  
• Raynaud's Treatment Study (RTS)
  ClinicalTrials.gov Identifier: NCT00000530 - Completed
  Cardiovascular Diseases; Heart Diseases; Raynaud's Disease; Vascular Diseases
  
• Study Designed to Evaluate the Safety of Prophylactic Depakote ER in the Treatment of Adolescents With Migraine
  ClinicalTrials.gov Identifier: NCT00195806 - Completed
  Migraine
  
• Evaluation of Effectiveness and Safety of Paliperidone ER (Extended-Release) Compared With Quetiapine in Patients With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00334126 - Completed
  Schizophrenia
  
• An Open Label, Double Blind Study Using Consecutive Intravenous Depacon With Oral Depakote ER for the Treatment of Cluster Headaches.
  ClinicalTrials.gov Identifier: NCT00203242 - Completed
  Cluster Headache
  
• A Randomized, Active-Controlled, Double-Blind, Parallel-Goup Study of the Efficacy and Safety of Extended Release(ER) Paliparidone in the Treatment of Schizophrenia
  ClinicalTrials.gov Identifier: NCT00350467 - Completed
  Acute Schizophrenia
  
• Asymptomatic Cardiac Ischemia Pilot (ACIP) Study
  ClinicalTrials.gov Identifier: NCT00000478 - Completed
  Cardiovascular Diseases; Coronary Disease; Heart Diseases; Myocardial Ischemia
  
• A Phase III Open-Label, Multi-Center, Long-Term Extension Study of Depakote ER in Subjects Who Either Completed or Prematurely Discontinued Due to Ineffectiveness From Study M02-488.
  ClinicalTrials.gov Identifier: NCT00195754 - Completed
  Migraines
  
• A Study of Galantamine as an Adjunctive Treatment to Atypical Antipsychotics in Schizophrenia Patients with Cognitive Deficits
  ClinicalTrials.gov Identifier: NCT00077727 - Completed
  Schizophrenia
  
• Registry for Acute Decompensated Heart Failure Patients Admitted to ER
  ClinicalTrials.gov Identifier: NCT00364325 - Completed
  Heart Decompensation; Heart Failure, Congestive
  
• An Inpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00060905 - Completed
  Bipolar Disorder
  
• Safety & Efficacy of a Combination Niacin ER/Simvastatin in Patients with Dyslipidemia: A Dose-Ranging Study - SEACOAST
  ClinicalTrials.gov Identifier: NCT00082251 - Completed
  Hypercholesterolemia
  
• Effect of Detrol LA on Overactive Bladder Symptoms, Sexual Quality of Life and Sexual Function in Women
  ClinicalTrials.gov Identifier: NCT00143481 - Completed
  Urinary Incontinence
  
• Divalproex ER vs. Risperidone for Bipolar Disorder With Comorbid Substance Use Disorder
  ClinicalTrials.gov Identifier: NCT00203528 - Completed
  Substance Abuse; Bipolar Depression
  
• Study Evaluating Venlafaxine ER in Children and Adolescents With Social Anxiety Disorder
  ClinicalTrials.gov Identifier: NCT00238719 - Completed
  Social Anxiety Disorder
  
• An Outpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder in Children and Adolescents
  ClinicalTrials.gov Identifier: NCT00067262 - Completed
  Bipolar Disorder